Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Lisa, K; Michail, G; Joshua, M; Alexandra, GE; Stefan, K; Julian, H; Dominika, M; Mira, K; Susanne, W; Marco, DG; Thomas, G; Hannes, D; Lukas, MS; Jens, F; Ulrike, E; Florian, H; Urs, F; Zsolt, K; Pasquale, M; Marios-Nikos, P; Ruth, GE; Christian, N; Christian, N; Julia, F; Tomas, D; Sven, P; Marek, S.
Thrombectomy with and without emergent stenting in acute ischemic stroke due to carotid artery dissection
EUR STROKE J. 2026; 11(1): aakaf004
Doi: 10.1093/esj/aakaf004
Web of Science
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Deutschmann Hannes
-
Gattringer Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Introduction Whether thrombectomy with or without emergent carotid stenting improves outcomes in patients with large vessel occlusion (LVO) stroke due to carotid artery dissection (CAD) is unknown.Patients and methods International multicentre observational study. Patients with LVO due to CAD undergoing thrombectomy with emergent stenting were compared to those without emergent stenting. The primary outcome was functional independence (modified Rankin Scale 0-2) at 3 months, secondary outcomes included early neurological improvement (ENI) within 24-48 h, successful recanalisation, symptomatic intracerebral haemorrhage (sICH) and mortality at 3 months. Inverse probability of treatment weighting and multivariable Poisson regression were used to adjust for group imbalances and to estimate the effect size, respectively. Results Of 516 patients (mean age 53.8 years, 76% male) undergoing thrombectomy, 167 (32.4%) and 349 (67.6%) were treated with or without emergent carotid stenting, respectively. After robust adjustment, emergent stenting was not associated with functional independence (adjusted risk ratio [aRR] = 1.01; 95% confidence interval [CI], 0.89-1.15) or ENI (aRR = 1.07; 95% CI, 0.95-1.21) but with successful recanalisation (aRR = 1.29; 95% CI, 1.10-1.50) and reduced mortality at 3 months (aRR = 0.39; 95% CI, 0.15-0.99). Risk of sICH was equivalent (aRR = 1.01; 95% CI, 0.95-1.06). Conclusion In patients with LVO secondary to CAD, emergent stenting during endovascular procedure appeared safe, increased odds of successful recanalisation and reduced 3-month mortality rates. However, intraprocedural stenting was not associated with better functional outcome.
- Find related publications in this database (Keywords)
-
thrombectomy
-
stenting
-
dissection
-
stroke
-
outcome